Evidence map›Paper›PMID 34540616›Full record

ArticleInternational journal of ophthalmology2021

Simultaneous pars plana vitrectomy, panretinal photocoagulation, cryotherapy, and Ahmed valve implantation for neovascular glaucoma.

Carolina Bernal-Morales, Marina Dotti-Boada, Alvaro Olate-Perez, Manuel J Navarro-Angulo, Laura Pelegrín, Marc Figueras-Roca

Open access · goldAbstract read
In one paragraph

Article in International journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Research Progress of Diabetes-related Glaucoma: Mechanisms, Impacts and Management Strategies.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  2. Observational
  3. Article
  4. Long-term outcomes of pars plana Ahmed valve implant and vitrectomy in eyes with refractory glaucoma.Medical hypothesis, discovery & innovation ophthalmology journal · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Carolina Bernal-MoralesInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Marina Dotti-BoadaInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Alvaro Olate-PerezInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Manuel J Navarro-AnguloInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Laura PelegrínInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Marc Figueras-RocaInstitut Clínic d'Oftalmologia (ICOF), Hospital Clínic, Barcelona 08028, Spain.
Hospital Clínic de Barcelona · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo describe and evaluate the efficacy of Ahmed glaucoma valve implantation (AGV) combined with pars plana vitrectomy (PPV) in a single surgical act for the treatment of advanced neovascular glaucoma (NVG).

methodsRetrospective observational case series included 51 eyes from 50 patients with severe NVG treated with PPV, AGV, and panretinal photocoagulation and/or cryotherapy in a single surgical act during a 13-year period (2005-2018). Preoperative, intraoperative and postoperative data at day 1 and months 1, 3, 6, 21, and 24 were systematically collected. Definition of surgical success was stablished at IOP between 6 and 21 mm Hg with or without topical treatment.

resultsMain indications for surgery were NVG secondary to proliferative diabetic retinopathy (39.2%) and central retinal vein occlusion (37.3%). Mean (±SD) preoperative IOP was 42.0±11.2 mm Hg decreasing to 15.5±7.1 mm Hg at 12mo and 15.8±9.1 mm Hg at 24mo of follow up. Cumulative incidence of success of IOP control was 76.0% at first postoperative month, reaching 88.3% at 6mo. Prevalence of successful IOP control at long term was 74.4% at 12mo and 71.4% at 24mo. Eye evisceration for unsuccessful NVG management was required in 1 case (2.0%).

conclusionCombination of AGV implantation and PPV in a single act may be a suitable option for severe forms of NVG in a case-by-case basis for effective IOP control and a complete panretinal photocoagulation.

Indexed as

Ahmed valvecryotherapyneovascular glaucomapanretinal photocoagulationpars plana vitrectomy

Identifiers

PMID34540616
PMCPMC8403848
OpenAlexW3194565440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.